by Plus Therapeutics | Jan 1, 2025 | Uncategorized
ReSPECT Clinical Trials on BrainsFortheCure.org What is Recurrent Glioblastoma (GBM)? Recurrent glioblastoma is a particularly aggressive form of brain cancer that tends to return after initial treatment. GBM recurrence is a major challenge for both patients and...
by Plus Therapeutics | Dec 25, 2024 | Uncategorized
Missed Plus Therapeutics at SNO Annual 2024? Catch Our Latest Presentations Online – Including ReSPECT-LM Phase 1 Interim Data If you weren’t able to attend the SNO Annual Meeting 2024 this year, don’t worry – you can now access all our key presentations online! This...
by Plus Therapeutics | Dec 23, 2024 | Uncategorized
🎄 Happy Holidays from Plus Therapeutics! 🎄 As the end of year year approaches, the Plus Therapeutics team wants to extend our warmest holiday greetings to all of our patients, partners, and supporters. We are taking some time this week to relax and recharge with our...
by Plus Therapeutics | Dec 19, 2024 | GBM
🎗️ Now Streaming: ReSPECT-GBM Patient Story – Jim’s Journey as a Recurrent Glioblastoma Survivor Watch Jim’s Inspiring Story Now on YouTube: Watch Jim’s Story Dr. Jim Stockand, a dedicated educator with a PhD in Physiology, has devoted the past 24 years to...
by Plus Therapeutics | Dec 18, 2024 | GBM
❗NEW CLINICAL TRIAL SITE NOW ENROLLING PATIENTS: ReSPECT-GBM at North Shore University Hospital❗ We are excited to announce a new clinical trial investigation site for the ReSPECT-GBM clinical trial: North Shore University Hospital @NorthwellHealth in New York. Under...
Recent Comments